mPulse Concludes 2024 on a High Note and Launches AI Center of Excellence to Drive Innovation in Healthcare mPulse®, a leader in Health Experience and Insights (HXI) technology, has announced…
Hinge Health Study Demonstrates Significant Reduction in Chronic Pelvic Pain and Depression Symptoms Chronic Pelvic Pain Hinge Health has announced the publication of a groundbreaking study in BMC Women’s Health…
Edifecs Unveils Healthcare Interoperability Cloud: A Strategic Leap Toward Seamless Data Exchange Edifecs a global leader in health information technology solutions, has announced the launch of its Healthcare Interoperability Cloud,…
Pediatric Genetic Fore Genomics Partners with Inocras to Revolutionize Pediatric Genetic Health Screening and Newborn Sequencing Pediatric Genetic Fore Genomics, a leading provider of pediatric genetic health screening, has announced…
Clinical Innovation UNC Health Expands Use of Abridge AI Technology to Enhance Patient and Clinician Experience Clinical Innovation UNC Health, one of the largest and most comprehensive healthcare systems in…
Understanding Cell and Gene Therapy Trials for Pediatric Rare Diseases: Join the Upcoming Xtalks Webinar Cell and gene therapy (CGT) has emerged as a promising treatment for rare diseases, particularly…
TriLink BioTechnologies Partners with Avantor to Expand Nucleic Acid Solutions in EMEA Region TriLink BioTechnologies® (TriLink), a global leader in providing life science reagents and services, has announced a strategic…
Inhalon Biopharma Advances Breakthrough Inhaled Antibody Treatment for RSV, Targets 2026 Human Trials Inhalon Biopharma, Inc., a clinical-stage company pioneering innovative treatments for acute respiratory infections (ARI), has announced a…
Bioscience B.V., a pioneering commercial-stage specialty pharmaceutical company dedicated to advancing life-changing medicines for rare disease patients across Europe, has announced the appointment of Abdelghani (Abdel) Omari as its first-ever…
Vertex Pharmaceuticals Announces Landmark Reimbursement Agreement with NHS England, Expanding Access to CASGEVY® for Sickle Cell Disease Patients Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has revealed a significant milestone in the…
TWYMEEG® Sales Performance and Forecast Update Poxel’s Partner Sumitomo Pharma Reports TWYMEEG® Sales for Q4 and FY 2024 in Japan A clinical-stage biopharmaceutical company dedicated to developing innovative treatments for…
KORU Medical Systems Announces Strategic Collaboration for Phase III Clinical Trial on Expanded Drug Indication for Rare Renal Disorder KORU Medical Systems (NASDAQ: KRMD), a prominent medical technology company focused…